| [1] |
Foster PA.Oestrogen and colorectal cancer：mechanisms and controversies.Int J Colorectal Dis，2013，28(6)：737-749.
|
| [2] |
Brenner H, Bouvier AM, Foschi R，et al.Progress of colorectal cancer survival in Europe，from the late 1980s to the early21st century: the EUROCARE study.IntJ Cancer，2012；131(7)：1649-1658.
|
| [13] |
Hendifar A, Yang D, Lenz F，et al.Gender disparities in metastatic colorectal cancer survival.Clin Cancer Res，2009，15(20)：6391–6397.
|
| [4] |
Fernandez E, Bosetti C, La Vecchia C，et al.Sexdifferences in colorectal cancer mortality in Europe，1955-1996.Eur J Cancer Prev，2000，9(2)：99-104.
|
| [5] |
Fraumeni JF Jr, Lloyd JW, Smith EM，et al.Cancer mortality among nuns：role of marital status in aetiology of neoplastic disease in women.J Natl Cancer Inst，1969；42(3)：455-468.
|
| [6] |
Delellis HK, Duan L, Sullivan–Halley J，et al.Menopausal hormone therapy use and risk of invasive colon cancer.Am J Epidemiol，2010，171(4)：415-425.
|
| [7] |
Ritenbaugh C, Stanford JL, Wu L，et al.Conjugated equine estrogens and colorectal cancer incidence and survival：the Women’s Health Initiative randomized clinical trial.Cancer Epidemiol Biomarkers Prev，2008，17(10)：2609-2618.
|
| [8] |
Rossouw JE, Anderson GL, Prentice RL，et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial.J Am MedAssocia，2002，288(3)：321–333.
|
| [9] |
Cleveland AG, Oikarinen SI, Bynote KK，et al.Disruption of estrogen receptor signaling enhances intestinal neoplasiain Apc(Min/＋)mice.Carcinogenesis，2009，30(9)：1581-1590.
|
| [10] |
Lin JK, Cheung WY, Lai JY-C，et al.The effect of estrogen vs.combined estrogen progestogen therapy on the risk of colorectal cancer.Int J Cancer，2012，130(2)：419-430.
|
| [11] |
Stocco C．Tissue physiology and pathology of aromatase.Steroids，2012；77(1)：27-35.
|
| [12] |
Rice S, Patel B, Bano G，et al.Aromatase expression in abdominal omental/visceral and subcutaneous fatdepots：a comparison of pregnant and obese women.Fertility and Sterility，2012，97(6)：1460-1466.
|
| [13] |
Boon WC, Chow JD, Simpson ER.The multiple roles of estrogens and the enzyme aromatase.Prog Brain Res，2010，181: 209-232.
|
| [14] |
Dey P, Barros RP, Warner M，et al.Insight into the mechanisms of action of estrogen receptor β in the breast，prostate，colon，and CNS.J Mol Endocrine，2013，51(3)：61-74.
|
| [15] |
Bòttner M, Thelen P, Jarry H．Estrogen receptor beta：tissue distribution and the still largely enigmatic physiological function.J Steroid Biochem Mol Biol，2014，139：245-251.
|
| [16] |
Deroo BJ, Buensuceso AV.Minireview：estrogen receptor-beta：mechanistic insights from recent studies.Mol Endocrinol，2010，24(9)：1703-1714.
|
| [17] |
Walter P, Green S, Greene G，et al.Cloning of the human estrogen receptor cDNA.PNAS，1985，82(23)：7889-7893.
|
| [18] |
Kuiper GG, Carlsson B, Grandien K，et al.Comparison of the ligand binding specificity and transcripttissue distribution of estrogen receptors α and β.Endocrinology，1997，138(3): 863-870.
|
| [19] |
Pettersson K, Gustafsson JA.Role of estrogen receptor βb in estrogenaction.Annual Review Physiol，2001，63(3)：165-192.
|
| [20] |
Campbell-Thompson M, Lynch IJ, Bhardwaj B．Expression of estrogen receptor(ER)subtypes and ERbeta isoforms in colon cancer.Cancer Res，2001，61(2): 632-640.
|
| [21] |
Acconcia F, Marino M．The effects of 17β -estradiol in cancer are mediated by estrogen receptor signaling at the plasma membrane.Frontiers in Physiology，2011，2(30)：301-308.
|
| [22] |
Thomas C, Gustafsson JÁ．The different roles of ER subtypes in cancer biology and therapy.Nat Rev Cancer，2011，11(8)：597-608.
|
| [23] |
Marino M, Pellegrini M, Acconcia F，et al.Susceptibility of estrogen receptor rapid responses to xenoestrogens：Physiological outcomes.Steroids，2012，77(10)：910-917.
|
| [24] |
Fiorelli G, Picariello L, Martineti V，et al.Estrogen synthesis in human colon cancer epithelial cells.J Steroid Biochem Mol Biol，1999，71(5-6)：223-230.
|
| [25] |
Maria Marino.Xenoestrogens challenge 17β-estradiol protective effects incolon cancer.World J Gastrointest Oncol，2014，6(3)：67-73.
|
| [26] |
Koehler KF, Helquero LA, Haldosén LA，et al.Reflections on the discovery and significance of estrogen receptor beta.Endocr Rev，2005，26(3)：465-478.
|
| [27] |
Qui Y, Waters CE, Lewis AE，et al.Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta.J Endocrinol，2002，174(3)：369-377.
|
| [28] |
Trinei M, Giorgio M, Cicalese A，et al.A p53-p66Shc signalling pathway controls intracellular redox status，levels of oxidation-damaged DNA and oxidative stress-induced apoptosis.Oncogene，2002，21(24)：3872-3878.
|
| [29] |
Galimov ER, Chernyak BV, Sidorenko AS，et al.Prooxodant properties of p66Shc are mediated by mitocho- ndria in human cells.PLos one，2014，9(3)：1-10.
|
| [30] |
Barzi A, Lenz AM, Labonte MJ，et al.Molecular Pathways：Estrogen Pathway in Colorectal Cancer.Clin Cancer Res，2013，19(21)：5842-5848.
|